ID   PLCL1_HUMAN             Reviewed;        1095 AA.
AC   Q15111; Q3MJ90; Q53SD3; Q7Z3S3;
DT   26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 3.
DT   10-MAY-2017, entry version 142.
DE   RecName: Full=Inactive phospholipase C-like protein 1;
DE            Short=PLC-L1;
DE   AltName: Full=Phospholipase C-deleted in lung carcinoma;
DE   AltName: Full=Phospholipase C-related but catalytically inactive protein;
DE            Short=PRIP;
GN   Name=PLCL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND TISSUE SPECIFICITY.
RX   PubMed=7633416; DOI=10.1093/hmg/4.4.667;
RA   Kohno T., Otsuka T., Takano H., Yamamoto T., Hamaguchi M., Terada M.,
RA   Yokota J.;
RT   "Identification of a novel phospholipase C family gene at chromosome
RT   2q33 that is homozygously deleted in human small cell lung
RT   carcinoma.";
RL   Hum. Mol. Genet. 4:667-674(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   ILE-667.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 741-1095.
RC   TISSUE=Rectum tumor;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   INTERACTION WITH PPP1C.
RX   PubMed=11278544; DOI=10.1074/jbc.M009677200;
RA   Yoshimura K., Takeuchi H., Sato O., Hidaka K., Doira N., Terunuma M.,
RA   Harada K., Ogawa Y., Ito Y., Kanematsu T., Hirata M.;
RT   "Interaction of p130 with, and consequent inhibition of, the catalytic
RT   subunit of protein phosphatase 1alpha.";
RL   J. Biol. Chem. 276:17908-17913(2001).
RN   [6]
RP   INTERACTION WITH GABARAP AND PPP1C.
RX   PubMed=11867528; DOI=10.1093/emboj/21.5.1004;
RA   Kanematsu T., Jang I.S., Yamaguchi T., Nagahama H., Yoshimura K.,
RA   Hidaka K., Matsuda M., Takeuchi H., Misumi Y., Nakayama K.,
RA   Yamamoto T., Akaike N., Hirata M., Nakayama K.;
RT   "Role of the PLC-related, catalytically inactive protein p130 in
RT   GABA(A) receptor function.";
RL   EMBO J. 21:1004-1011(2002).
RN   [7]
RP   INTERACTION WITH PPP1C; GABA A RECEPTOR SUBUNIT BETA; GABA A RECEPTOR
RP   AND SUBUNIT GAMMA-2.
RX   PubMed=16404143;
RA   Kanematsu T., Takeuchi H., Terunuma M., Hirata M.;
RT   "PRIP, a novel Ins(1,4,5)P3 binding protein, functional significance
RT   in Ca2+ signaling and extension to neuroscience and beyond.";
RL   Mol. Cells 20:305-314(2005).
RN   [8]
RP   INTERACTION WITH PPP1C.
RX   PubMed=16854455; DOI=10.1016/j.advenzreg.2006.01.006;
RA   Yanagihori S., Terunuma M., Koyano K., Kanematsu T., Ho Ryu S.,
RA   Hirata M.;
RT   "Protein phosphatase regulation by PRIP, a PLC-related catalytically
RT   inactive protein -- implications in the phospho-modulation of the
RT   GABAA receptor.";
RL   Adv. Enzyme Regul. 46:203-222(2006).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=16952428; DOI=10.1016/j.gene.2006.07.005;
RA   Murakami A., Matsuda M., Nakasima A., Hirata M.;
RT   "Characterization of the human PRIP-1 gene structure and
RT   transcriptional regulation.";
RL   Gene 382:129-139(2006).
RN   [10]
RP   INTERACTION WITH GABA A RECEPTOR.
RX   PubMed=16754670; DOI=10.1074/jbc.M603118200;
RA   Jovanovic J.N., Takenaka K., Nakayama K.I., Fukami K., Takenawa T.,
RA   Moss S.J., Nabekura J., Hirata M.;
RT   "Modulation of GABA(A) receptor phosphorylation and membrane
RT   trafficking by phospholipase C-related inactive protein/protein
RT   phosphatase 1 and 2A signaling complex underlying brain-derived
RT   neurotrophic factor-dependent regulation of GABAergic inhibition.";
RL   J. Biol. Chem. 281:22180-22189(2006).
RN   [11]
RP   FUNCTION.
RX   PubMed=17254016; DOI=10.1111/j.1471-4159.2006.04399.x;
RA   Kanematsu T., Fujii M., Mizokami A., Kittler J.T., Nabekura J.,
RA   Moss S.J., Hirata M.;
RT   "Phospholipase C-related inactive protein is implicated in the
RT   constitutive internalization of GABAA receptors mediated by clathrin
RT   and AP2 adaptor complex.";
RL   J. Neurochem. 101:898-905(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND SER-95, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Involved in an inositol phospholipid-based intracellular
CC       signaling cascade. Shows no PLC activity to phosphatidylinositol
CC       4,5-bisphosphate and phosphatidylinositol. Component in the
CC       phospho-dependent endocytosis process of GABA A receptor (By
CC       similarity). Regulates the turnover of receptors and thus
CC       contributes to the maintenance of GABA-mediated synaptic
CC       inhibition. Its aberrant expression could contribute to the
CC       genesis and progression of lung carcinoma. Acts as an inhibitor of
CC       PPP1C. {ECO:0000250, ECO:0000269|PubMed:17254016}.
CC   -!- SUBUNIT: Interacts with PPP2CA (By similarity). Interacts with
CC       Ins(1,4,5)P3, Ins(1,4,5,6)P4, GABARAP, GABA receptor beta
CC       subunits, GABA receptor gamma-2 subunits and PPP1C. May form a
CC       ternary complex with GABA receptor beta subunit and GABARAP. The
CC       formation of a ternary complex with GABA receptor beta subunit and
CC       GABARAP could be the key step for facilitating the association of
CC       GABARAP with the GABA receptor gamma-2 subunit and to allow it to
CC       be transported at the right destination. {ECO:0000250,
CC       ECO:0000269|PubMed:11278544, ECO:0000269|PubMed:11867528,
CC       ECO:0000269|PubMed:16404143, ECO:0000269|PubMed:16754670,
CC       ECO:0000269|PubMed:16854455}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15111-1; Sequence=Displayed;
CC         Note=No experimental confirmation available.;
CC       Name=2;
CC         IsoId=Q15111-2; Sequence=VSP_031475;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of fetal and adult
CC       organs including brain, lung and kidney. Its expression was
CC       greatly reduced in small and non-small cell lung carcinoma.
CC       Isoform 1 is predominantly expressed in brain.
CC       {ECO:0000269|PubMed:16952428, ECO:0000269|PubMed:7633416}.
CC   -!- PTM: Phosphorylated by the catalytic subunit of PKA.
CC       Phosphorylation of Thr-93 resulted in dissociation of PPP1C from
CC       PRIP1 (By similarity). {ECO:0000250}.
CC   -!- CAUTION: In the PI-PLC X-box Asn-458 is present instead of the
CC       conserved His which is one of the active site residues. It is
CC       therefore expected that this protein lacks catalytic activity.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D42108; BAA07688.1; -; mRNA.
DR   EMBL; AC011997; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013478; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC020719; AAY14733.1; -; Genomic_DNA.
DR   EMBL; BC101531; AAI01532.1; -; mRNA.
DR   EMBL; BC111985; AAI11986.1; -; mRNA.
DR   EMBL; BX537442; CAD97684.1; -; mRNA.
DR   CCDS; CCDS2326.2; -. [Q15111-1]
DR   PIR; I54390; I54390.
DR   RefSeq; NP_006217.3; NM_006226.3. [Q15111-1]
DR   RefSeq; XP_016859829.1; XM_017004340.1. [Q15111-2]
DR   UniGene; Hs.153322; -.
DR   ProteinModelPortal; Q15111; -.
DR   SMR; Q15111; -.
DR   STRING; 9606.ENSP00000402861; -.
DR   DrugBank; DB01103; Quinacrine.
DR   iPTMnet; Q15111; -.
DR   PhosphoSitePlus; Q15111; -.
DR   BioMuta; PLCL1; -.
DR   DMDM; 226694170; -.
DR   MaxQB; Q15111; -.
DR   PaxDb; Q15111; -.
DR   PeptideAtlas; Q15111; -.
DR   PRIDE; Q15111; -.
DR   Ensembl; ENST00000428675; ENSP00000402861; ENSG00000115896. [Q15111-1]
DR   GeneID; 5334; -.
DR   KEGG; hsa:5334; -.
DR   UCSC; uc010fsp.4; human. [Q15111-1]
DR   CTD; 5334; -.
DR   DisGeNET; 5334; -.
DR   GeneCards; PLCL1; -.
DR   H-InvDB; HIX0023967; -.
DR   HGNC; HGNC:9063; PLCL1.
DR   HPA; HPA031849; -.
DR   MIM; 600597; gene.
DR   neXtProt; NX_Q15111; -.
DR   OpenTargets; ENSG00000115896; -.
DR   PharmGKB; PA33394; -.
DR   eggNOG; KOG0169; Eukaryota.
DR   eggNOG; ENOG410XPSW; LUCA.
DR   GeneTree; ENSGT00760000118936; -.
DR   HOGENOM; HOG000006871; -.
DR   InParanoid; Q15111; -.
DR   KO; K15375; -.
DR   OMA; CSLPQQK; -.
DR   OrthoDB; EOG091G00S7; -.
DR   PhylomeDB; Q15111; -.
DR   TreeFam; TF313216; -.
DR   BRENDA; 2.7.11.10; 2681.
DR   ChiTaRS; PLCL1; human.
DR   GenomeRNAi; 5334; -.
DR   PRO; PR:Q15111; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115896; -.
DR   CleanEx; HS_PLCL1; -.
DR   ExpressionAtlas; Q15111; baseline and differential.
DR   Genevisible; Q15111; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0050811; F:GABA receptor binding; IEA:InterPro.
DR   GO; GO:0070679; F:inositol 1,4,5 trisphosphate binding; IEA:InterPro.
DR   GO; GO:0004435; F:phosphatidylinositol phospholipase C activity; IEA:InterPro.
DR   GO; GO:0004629; F:phospholipase C activity; TAS:ProtInc.
DR   GO; GO:0004871; F:signal transducer activity; IEA:UniProtKB-KW.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:InterPro.
DR   GO; GO:1900122; P:positive regulation of receptor binding; IEA:Ensembl.
DR   GO; GO:0033135; P:regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.60.40.150; -; 1.
DR   Gene3D; 3.20.20.190; -; 1.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR001192; PI-PLC_fam.
DR   InterPro; IPR017946; PLC-like_Pdiesterase_TIM-brl.
DR   InterPro; IPR015359; PLC_EF-hand-like.
DR   InterPro; IPR028382; PLCL1.
DR   InterPro; IPR000909; PLipase_C_PInositol-sp_X_dom.
DR   InterPro; IPR001711; PLipase_C_Pinositol-sp_Y.
DR   PANTHER; PTHR10336; PTHR10336; 1.
DR   PANTHER; PTHR10336:SF129; PTHR10336:SF129; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF09279; EF-hand_like; 1.
DR   Pfam; PF16457; PH_12; 1.
DR   Pfam; PF00388; PI-PLC-X; 1.
DR   Pfam; PF00387; PI-PLC-Y; 1.
DR   PRINTS; PR00390; PHPHLIPASEC.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00148; PLCXc; 1.
DR   SMART; SM00149; PLCYc; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF49562; SSF49562; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF51695; SSF51695; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50007; PIPLC_X_DOMAIN; 1.
DR   PROSITE; PS50008; PIPLC_Y_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Complete proteome; Cytoplasm;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transducer.
FT   CHAIN         1   1095       Inactive phospholipase C-like protein 1.
FT                                /FTId=PRO_0000319414.
FT   DOMAIN      113    223       PH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00145}.
FT   DOMAIN      398    542       PI-PLC X-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00270}.
FT   DOMAIN      585    701       PI-PLC Y-box. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00271}.
FT   DOMAIN      708    813       C2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   REGION       83    222       Interaction with PPP1C.
FT   REGION      543    567       Interaction with GABA A beta subunit.
FT                                {ECO:0000250}.
FT   COILED      894    914       {ECO:0000255}.
FT   COILED     1034   1059       {ECO:0000255}.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q3USB7}.
FT   MOD_RES      77     77       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      93     93       Phosphothreonine; by PKA. {ECO:0000250}.
FT   MOD_RES      95     95       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     556    556       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q3USB7}.
FT   MOD_RES     569    569       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62688}.
FT   MOD_RES    1079   1079       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q62688}.
FT   VAR_SEQ       1     98       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7633416}.
FT                                /FTId=VSP_031475.
FT   VARIANT     445    445       D -> N (in dbSNP:rs45506698).
FT                                /FTId=VAR_038993.
FT   VARIANT     454    454       P -> S (in dbSNP:rs45506696).
FT                                /FTId=VAR_038994.
FT   VARIANT     546    546       S -> F (in dbSNP:rs45596936).
FT                                /FTId=VAR_038995.
FT   VARIANT     667    667       V -> I (in dbSNP:rs1064213).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038996.
FT   VARIANT     684    684       W -> C (in dbSNP:rs6741084).
FT                                /FTId=VAR_038997.
FT   VARIANT     937    937       S -> N (in dbSNP:rs45452996).
FT                                /FTId=VAR_038998.
FT   CONFLICT    176    176       R -> T (in Ref. 1; BAA07688).
FT                                {ECO:0000305}.
FT   CONFLICT    563    563       E -> Q (in Ref. 1; BAA07688).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1095 AA;  122728 MW;  C7B34D38C654E2D3 CRC64;
     MAEGAAGRED PAPPDAAGGE DDPRVGPDAA GDCVTAASGG RMRDRRSGVA LPGAAGTPAD
     SEAGLLEAAR ATPRRSSIIK DPSNQKCGGR KKTVSFSSMP SEKKISSAND CISFMQAGCE
     LKKVRPNSRI YNRFFTLDTD LQALRWEPSK KDLEKAKLDI SAIKEIRLGK NTETFRNNGL
     ADQICEDCAF SILHGENYES LDLVANSADV ANIWVSGLRY LVSRSKQPLD FMEGNQNTPR
     FMWLKTVFEA ADVDGNGIML EDTSVELIKQ LNPTLKEAKI RLKFKEIQKS KEKLTTRVTE
     EEFCEAFCEL CTRPEVYFLL VQISKNKEYL DANDLMLFLE AEQGVTHITE DICLDIIRRY
     ELSEEGRQKG FLAIDGFTQY LLSSECDIFD PEQKKVAQDM TQPLSHYYIN ASHNTYLIED
     QFRGPADING YIRALKMGCR SVELDVSDGS DNEPILCNRN NMTTHVSFRS VIEVINKFAF
     VASEYPLILC LGNHCSLPQQ KVMAQQMKKV FGNKLYTEAP LPSESYLPSP EKLKRMIIVK
     GKKLPSDPDV LEGEVTDEDE EAEMSRRMSV DYNGEQKQIR LCRELSDLVS ICKSVQYRDF
     ELSMKSQNYW EMCSFSETEA SRIANEYPED FVNYNKKFLS RIYPSAMRID SSNLNPQDFW
     NCGCQIVAMN FQTPGPMMDL HTGWFLQNGG CGYVLRPSIM RDEVSYFSAN TKGILPGVSP
     LALHIKIISG QNFPKPKGAC AKGDVIDPYV CIEIHGIPAD CSEQRTKTVQ QNSDNPIFDE
     TFEFQVNLPE LAMIRFVVLD DDYIGDEFIG QYTIPFECLQ PGYRHVPLRS FVGDIMEHVT
     LFVHIAITNR SGGGKAQKRS LSVRMGKKVR EYTMLRNIGL KTIDDIFKIA VHPLREAIDM
     RENMQNAIVS IKELCGLPPI ASLKQCLLTL SSRLITSDNT PSVSLVMKDS FPYLEPLGAI
     PDVQKKMLTA YDLMIQESRF LIEMADTVQE KIVQCQKAGM EFHEELHNLG AKEGLKGRKL
     NKATESFAWN ITVLKGQGDL LKNAKNEAIE NMKQIQLACL SCGLSKAPSS SAEAKSKRSL
     EAIEEKESSE ENGKL
//
